Absorption |
Blood-Brain Barrier | BBB+ | 0.9952 |
Human Intestinal Absorption | HIA+ | 0.9973 |
Caco-2 Permeability | Caco2+ | 0.8867 |
P-glycoprotein Substrate | Substrate | 0.6077 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8447 |
Non-inhibitor | 0.9460 |
Renal Organic Cation Transporter | Non-inhibitor | 0.5915 |
Distribution |
Subcellular localization | Mitochondria | 0.5452 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7898 |
CYP450 2D6 Substrate | Non-substrate | 0.9116 |
CYP450 3A4 Substrate | Substrate | 0.7366 |
CYP450 1A2 Inhibitor | Inhibitor | 0.9355 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.5688 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.7513 |
CYP450 2C19 Inhibitor | Inhibitor | 0.6436 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7515 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6580 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9966 |
Non-inhibitor | 0.8768 |
AMES Toxicity | Non AMES toxic | 0.9132 |
Carcinogens | Non-carcinogens | 0.7881 |
Fish Toxicity | High FHMT | 0.6400 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9740 |
Honey Bee Toxicity | Low HBT | 0.8531 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.8085 |
Carcinogenicity (Three-class) | Non-required | 0.7582 |